CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | Sender Gary Director | Grant or award · Stock Option | +13,333 | 13,333 | ||
| 2021-05-20 | Nielsen Jack Director | Grant or award · Stock Option | +7,246 | 7,246 | ||
| 2021-05-20 | Motley Eric L Director | Grant or award · Stock Option | +7,246 | 7,246 | ||
| 2021-05-20 | Graf R. Mark Director | Grant or award · Stock Option | +7,246 | 7,246 | ||
| 2021-05-20 | Sabater Juan A. Director | Grant or award · Stock Option | +7,246 | 7,246 | ||
| 2021-03-29 | Kapadia Sandip Chief Financial Officer | Grant or award · Restricted Stock Units | +60,000 | 60,000 | ||
| 2021-03-29 | Kapadia Sandip Chief Financial Officer | Grant or award · Stock Option | +230,000 | 230,000 | ||
| 2020-11-11 | Motley Eric L Director | Grant or award · Stock Option | +4,604 | 4,604 | ||
| 2020-11-11 | Graf R. Mark Director | Grant or award · Stock Option | +4,604 | 4,604 | ||
| 2020-08-26 | Nielsen Jack Director | Purchase | +3,922 | $34.30 | $135K | 42,702 |
| 2020-08-25 | Nielsen Jack Director | Purchase | +823 | $34.20 | $28K | 38,780 |
| 2020-08-24 | Nielsen Jack Director | Purchase | +3,057 | $34.30 | $105K | 37,957 |
| 2020-08-21 | Marshman Fund Trust II 10% owner | Purchase | +339,476 | $24.00 | $8.1M | 10,651,120 |
| 2020-08-21 | Novo Holdings A/S 10% owner | Conversion | +3,622,470 | 3,754,973 | ||
| 2020-08-21 | Novo Holdings A/S 10% owner | Conversion · Series A Convertible Preferred Stock | −25,000,000 | 0 | ||
| 2020-08-21 | Novo Holdings A/S 10% owner | Conversion · Series C Convertible Preferred Stock | −1,860,107 | 0 | ||
| 2020-08-21 | Marshman Fund Trust II 10% owner | Conversion | +3,379,881 | 3,379,881 | ||
| 2020-08-21 | Marshman Fund Trust II 10% owner | Conversion · Series A Preferred Stock | −25,000,000 | 0 | ||
| 2020-08-21 | Serafin Andrew Chief Business Officer | Conversion | +33,693 | 33,693 | ||
| 2020-08-21 | Serafin Andrew Chief Business Officer | Conversion · Series A Preferred Stock | −200,000 | 0 |
Page 24 of 26 · 511 trades